Answer
CARVYKTI (ciltacabtagene autoleucel) must be stored and transported in the vapour phase of liquid nitrogen at ≤ −120 °C, with the infusion bag kept in its aluminium cryo cassette, and remain frozen until the patient is ready for treatment to ensure viable cells are available.
Sources for this answer
- CARVYKTI 3.2 × 10^6 – 1 × 10^8 cells dispersion for infusionJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §6.4 Special precautions for storage · Version 6Document updated
Sources checked